Overview

Safety and Efficacy Study of BRIMOCHOLâ„¢ in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

Status:
Not yet recruiting
Trial end date:
2023-03-31
Target enrollment:
0
Participant gender:
All
Summary
Safety and Efficacy Study of BRIMOCHOLâ„¢ in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia
Phase:
Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Visus Therapeutics
Treatments:
Brimonidine Tartrate
Carbachol
Criteria
Inclusion Criteria:

- Male or female in good general health

- Must have presbyopia

Exclusion Criteria:

- History of allergic reaction to the study drug or any of its components

- Any disease or medical condition that, in the opinion of the Investigator, would
prevent the subject from participating in the study or might confound study results